Global Patent Index - EP 1182929 A1

EP 1182929 A1 20020306 - OSTEONECTIN BASED TOXIC GENE THERAPY FOR THE TREATMENT OF CALCIFIED TUMORS AND TISSUES

Title (en)

OSTEONECTIN BASED TOXIC GENE THERAPY FOR THE TREATMENT OF CALCIFIED TUMORS AND TISSUES

Title (de)

AUF OSTEONECTIN BASIERTE TOXISCHE GENTHERAPIE ZUR BEHANDLUNG VON KALZIFIZIERTEN TUMOREN UND GEWEBEN

Title (fr)

THERAPIE GENIQUE TOXIQUE A BASE D'OSTEONECTINE DESTINEE AU TRAITEMENT DE TUMEURS ET DE TISSUS CALCIFIES

Publication

EP 1182929 A1 20020306 (EN)

Application

EP 00937791 A 20000525

Priority

  • US 0014482 W 20000525
  • US 13644099 P 19990528

Abstract (en)

[origin: WO0072679A1] The present invention relates to promoters, enhancers and other regulatory elements that direct expression within tumor and tissue cells with calcification potential. Specifically provided are expression vectors, host cells, and transgenic animals comprising an OSN regulatory region.

IPC 1-7

A01N 43/04

IPC 8 full level

G01N 33/50 (2006.01); A61K 9/127 (2006.01); A61K 31/522 (2006.01); A61K 31/711 (2006.01); A61K 35/76 (2006.01); A61K 38/00 (2006.01); A61K 38/22 (2006.01); A61K 38/43 (2006.01); A61K 48/00 (2006.01); A61P 19/00 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C12N 15/85 (2006.01); C12Q 1/66 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01)

CPC (source: EP)

A61K 48/00 (2013.01); A61P 19/00 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12); C12N 15/85 (2013.01); C12N 2830/008 (2013.01); C12N 2830/85 (2013.01)

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 0072679 A1 20001207; AU 5291800 A 20001218; CA 2374141 A1 20001207; EP 1182929 A1 20020306; EP 1182929 A4 20030416; IL 146794 A0 20020725; JP 2003500422 A 20030107

DOCDB simple family (application)

US 0014482 W 20000525; AU 5291800 A 20000525; CA 2374141 A 20000525; EP 00937791 A 20000525; IL 14679400 A 20000525; JP 2000620801 A 20000525